Compare Merck Tbk. (MERK) vs Kian Santang Muliatama Tbk. (RGAS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck Tbk. vs Kian Santang Muliatama Tbk. — how do they compare? Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume), while Kian Santang Muliatama Tbk. trades at Rp114 (market cap 163.43B, 36.43M 24h volume). The key difference: Merck Tbk. is far larger — about 10.8× Kian Santang Muliatama Tbk.'s market cap, and Kian Santang Muliatama Tbk. is more actively traded (36.43M versus 63K). Which is the better fit depends on your goals.
| MERK | RGAS | |
|---|---|---|
Market Cap | 1.76T | 163.43B |
Volume | 63K | 36.43M |
Lot | 630 | 364.26K |
Turnover | 243.97M | 4B |
Average Price | 3,872.46 | 109.89 |
Value | 243.97M | 4B |
Indicative Equilibrium Price | 3,900 | 114 |
Indicative Equilibrium Volume | 1 | 5.9K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →About Kian Santang Muliatama Tbk.
PT Kian Santang Muliatama Tbk (the Entity) was established based on the Notarial Deed of Artisa Khamelia Ramadiyanti, S.H., M.Kn., No. 634, dated November 28, 2018. The Entity started its commercial operations on 2019. The controlling party for the Company is Edy Nurhamid Amin.
Read more on RGAS →
